These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37935929)

  • 1. Cholinesterase inhibitors associated with lower rate of mortality in dementia patients with heart failure: a nationwide propensity weighting study.
    Hsieh MJ; Lee CH; Chen DY; Wu CL; Huang YT; Chang SH
    Clin Auton Res; 2023 Dec; 33(6):715-726. PubMed ID: 37935929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction.
    Shahim B; Xu H; Haugaa K; Zetterberg H; Jurga J; Religa D; Eriksdotter M
    Eur Heart J Cardiovasc Pharmacother; 2024 Feb; 10(2):128-136. PubMed ID: 38224338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry.
    Secnik J; Schwertner E; Alvarsson M; Hammar N; Fastbom J; Winblad B; Garcia-Ptacek S; Religa D; Eriksdotter M
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Cholinesterase Inhibitors and New-Onset Heart Failure in Patients With Alzheimer's Disease: A Nationwide Propensity Score Matching Study.
    Hsieh MJ; Chen DY; Lee CH; Wu CL; Chen YJ; Huang YT; Chang SH
    Front Cardiovasc Med; 2022; 9():831730. PubMed ID: 35369359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of overactive bladder associated with cholinesterase inhibitors in dementia.
    Masurkar PP; Chatterjee S; Sherer JT; Chen H; Johnson ML; Aparasu RR
    J Am Geriatr Soc; 2022 Mar; 70(3):820-830. PubMed ID: 34854475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia: A Systematic Review of Randomized and Nonrandomized Trials.
    Truong C; Recto C; Lafont C; Canoui-Poitrine F; Belmin JB; Lafuente-Lafuente C
    Neurology; 2022 Nov; 99(20):e2313-e2325. PubMed ID: 36096687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study.
    Stephenson A; Seitz DP; Fischer HD; Gruneir A; Bell CM; Gershon AS; Fu L; Anderson GM; Austin PC; Rochon PA; Gill SS
    Drugs Aging; 2012 Mar; 29(3):213-223. PubMed ID: 22332932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality.
    Xu H; Garcia-Ptacek S; Jönsson L; Wimo A; Nordström P; Eriksdotter M
    Neurology; 2021 Apr; 96(17):e2220-e2230. PubMed ID: 33741639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
    Seitz DP; Gill SS; Gruneir A; Austin PC; Anderson G; Reimer CL; Rochon PA
    Am J Geriatr Psychiatry; 2011 Sep; 19(9):803-13. PubMed ID: 21873836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study.
    Masurkar PP; Chatterjee S; Sherer JT; Chen H; Johnson ML; Aparasu RR
    Drugs Aging; 2022 Jun; 39(6):453-465. PubMed ID: 35666463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation.
    Fisher A; Carney G; Bassett K; Chappell NL
    Value Health; 2016; 19(5):688-96. PubMed ID: 27565287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association Between the Use of Cholinesterase Inhibitors and Cardiovascular Events Among Older Patients With Alzheimer Disease.
    Hsiao SH; Hwang TJ; Lin FJ; Sheu JJ; Wu CH
    Mayo Clin Proc; 2021 Feb; 96(2):350-362. PubMed ID: 33549256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia.
    Zhu L; Rochon PA; Gruneir A; Wu W; Giannakeas V; Austin PC; Stall NM; McCarthy L; Alberga A; Herrmann N; Gill SS; Bronskill SE
    Drugs Aging; 2019 Sep; 36(9):875-884. PubMed ID: 31309528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study.
    Rege S; Carnahan RM; Johnson ML; Chen H; Holmes HM; Aparasu RR
    Drugs Aging; 2021 Jun; 38(6):493-502. PubMed ID: 33763822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinesterase Inhibitor Use in Patients With Dementia Admitted to a Palliative Care Unit.
    Perri GA; Wilson J; Gardner S; Berall A; Kirstein A; Khosravani H
    Am J Hosp Palliat Care; 2021 Nov; 38(11):1356-1360. PubMed ID: 33401952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase inhibitor use in U.S. nursing homes: results from the national nursing home survey.
    Seitz DP; Gruneir A; Conn DK; Rochon PA
    J Am Geriatr Soc; 2009 Dec; 57(12):2269-74. PubMed ID: 19874411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease.
    Nordström P; Religa D; Wimo A; Winblad B; Eriksdotter M
    Eur Heart J; 2013 Sep; 34(33):2585-91. PubMed ID: 23735859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment.
    Pyun JM; Ryoo N; Park YH; Kim S
    Alzheimers Res Ther; 2021 Jan; 13(1):10. PubMed ID: 33402198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study.
    Chitnis AS; Aparasu RR; Chen H; Kunik ME; Schulz PE; Johnson ML
    Drugs Aging; 2015 Sep; 32(9):743-54. PubMed ID: 26363909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.